BioSpace News Archive

Business

Telix Pharmaceuticals and JFE Announce Japanese Radiopharmaceutical Manufacturing Partnership

JFE is an engineering and manufacturing company with extensive expertise in the installation of cyclotron infrastructure and radiopharmaceutical manufacturing in Japan.

December 13, 2017
·
3 min read
Pharm Country

Dentsply Sirona Declares Quarterly Cash Dividend - Dec. 13, 2017

The dividend is payable on January 12, 2018 to holders of record on December 29, 2017.

December 13, 2017
·
1 min read
Deals

Denali Therapeutics Announces Closing of Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Goldman Sachs & Co. LLC, Morgan Stanley and J.P. Morgan acted as joint book-running managers for the offering, and Evercore Group L.L.C. acted as lead manager for the offering.

December 13, 2017
·
1 min read
Genetown

Proteostasis Therapeutics Announces Proposed Public Offering of Common Stock

Leerink Partners LLC and RBC Capital Markets, LLC are acting as joint book-running managers for the offering.

December 13, 2017
·
4 min read
Pharm Country

Brainsway Raises $8.5M From Leading Israeli Investors

The financing was led by the Phoenix Group (Israel), which will own more than 7% in the Company.

December 13, 2017
·
3 min read
Bio NC

Fennec Announces Closing of Public Offering

The total gross proceeds from the offering (before deducting the underwriting discounts and offering expenses) was $21,153,270.

December 13, 2017
·
3 min read
Essilor - News Release: Capital Increase Reserved for Employees

The maximum number of common shares previously authorized for issuance was 3,107,595[2].

December 13, 2017
·
3 min read
Business

Shineco Announces RMB 8 Million Contract with Huangpu International Limited

Pursuant to the Contract, Huangpu is expected to purchase RMB 8 million worth of products from Shineco and is expected to distribute Shineco’s products through its e-commence platform at www.xiaohongshu.com.

December 13, 2017
·
3 min read
Resverlogix Announces Voting Results From The 2017 Annual Meeting Of Shareholders

Resverlogix shareholders approved all resolutions outlined in the Notice of Meeting and Management Information Circular dated October 30, 2017.

December 13, 2017
·
2 min read
Eisai’s Aricept Approved for Additional Indication of Severe Alzheimer’s Disease in China

The approval of the additional indication was based on the results of a Phase III clinical study in China.

December 13, 2017
·
4 min read